Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using a panel of peptides derived from envelope protein for serodiagnosis

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 2, 2014, Pages 297-307

  Verma, Priyanka ^a   Bhatnagar, Santwana ^a   Kumar, Pradeep ^a   Chattree, Vinita ^a   Parida, M M ^b   Hoti, S L ^c   Ali, Shakir ^d   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

^c VECTOR CONTROL RESEARCH CENTRE   (India)

^d HAMDARD UNIVERSITY   (India)

Author keywords

CHIKV; ELISA; Envelope protein; Epitopes; Peptides

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; INDIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS STRAIN;

ALPHAVIRUS INFECTIONS; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; CHIKUNGUNYA VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; ROC CURVE; VIRAL ENVELOPE PROTEINS;

EID: 84896267199     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0363     Document Type: Article

References (52)

1. Sudeep AB, Parashar D. Chikungunya: an overview. J Biosci 2008;33:443-9.
2. Yadav JS. A special issue on chikungunya. Envis News Letter 2006;3:1-12.
3. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nature Rev 2010;8:491-500.
4. Solignata M, Gaya B, Higgs S, Brianta L, Devauxa C. Replication cycle of chikungunya: a re-emerging arbovirus. Virology 2009;393:183-97.
5. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public health disaster. Lancet Infect Dis 2007;7:306-7.
6. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006;3:e263.
7. Pastorino B, Muyembe-Tamfum JJ, Bessaud M, Tock F, Tolou H, Durand JP, et al. Epidemic resurgence of chikungunya virus in Democratic Republic of the Congo: identification of a new Central African strain. J Med Virol 2004;74:277-82.
8. Hochedez P, Hausfater P, Jaureguiberry S, Gay F, Datry A, Danis M, et al. Cases of chikungunya fever imported from the islands of the South West Indian Ocean to Paris, France. Euro Surveill 2007;12:1.
9. Lim PL, Oh HM, Ooi EE. Chikungunya in Singapore: imported cases among travelers visiting friends and relatives. J Travel Med 2009;16:289-91.
10. Centers for Disease Control and Prevention (CDC) Update: chikungunya fever diagnosed among international travelers United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:276-7.
11. Mavalankar D, Shastri P, Bandyopadhyay T, Parmar J, Ramani KV. Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis 2008;14:412-5.
12. Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P, et al. A typical chikungunya virus infection: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreaks on Reunion. Epidemiol Infect 2009;137:534-41.
13. Tesh RB. Arthritides caused by mosquito-borne viruses. Annu Rev Med 1982;33:31-40.
14. Queyriaux B, Simon F, Grandadam M, Michel R, Tolou H, Boutin JP. Clinical burden of chikungunya virus infection. Lancet Infect Dis 2008;8:2-3.
15. Dupuis Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P Chikungunya disease: infection associated markers from the acute to the chronic phase of arbovirus-induce arthralgia. Plos 2012;6:e1446.
16. Ummul HA, Vasan SS, Ravindran T, Chandru A, Lee HL, Shamala DS. Development and evaluation of a one-step SYBR-Green I-based real-time RT-PCR assay for the detection and quantification of chikungunya virus in human, monkey and mosquito samples. Tropical Biomed 2010;27:611-23.
17. Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A. Evaluation of chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS 2010;4:e753.
18. Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel Benhassine F, et al. A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008;4:e29.
19. Smith DR, Lee JS, Jahrling J, Kulesh DA, Turell MJ, Groebner JL, et al. Development of field-based real-time reverse transcription-polymerase chain reaction assays for detection of chikungunya and o'nyong-nyong viruses in mosquitoes. Am J Trop Med Hyg 2009;81:679-84.
20. Parida MM, Santhosh SR, Dash PK, Tripathi NK, Lakshmi V, Mamidi N, et al. Rapid and real-time detection of chikungunya virus by reverse transcription loop-mediated isothermal amplification assay. J Clin Microbiol 2007;45:351-7.
21. Shukla J, Khan M, Tiwari M, Sannarangaiah S, Sharma S, Rao PV, et al. Development and evaluation of antigen capture ELISA for early clinical diagnosis of chikungunya. Diagn Microbiol Infect Dis 2009;65:142-9.
22. Chen H, Takei F, Koay ES, Nakatani K, Chu JJ. A novel DANP-coupled hairpin RT-PCR for rapid detection of chikungunya virus. J Mol Diagn 2013;15:227-33.
23. Gerardin P, Guernier V, Perrau J, Fianu A, Le Roux K, Grivard P, et al. Estimating chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 2008;8:99.
24. Rampal, Sharda M, Meena H. Neurological complications in chikungunya fever. J Assoc Physicians India 2007;55:765-9.
25. Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, et al. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 2008;149:175-9.
26. Thon-Hon VG, Denizot M, Li-Pat-Yuen G, Giry C, Jaffar-Bandjee MC, Gasque P. Deciphering the differential response of two human fibroblast cell lines following chikungunya virus infection. Virol J 2012;9:213.
27. Saluzzo JF, Gonzalez JP, Hervé JP, Georges AJ. Serological survey for the prevalence of certain arboviruses in the human population of the south-east area of Central African Republic. Bull Soc Pathol Exot Filiales 1981;5:490-9.
28. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958;7:561-73.
29. Alcaro MC, Peroni E, Rovero P, Papini AM. Synthetic peptides in the diagnosis of HIV infection. Curr Protein Pept Sci 2003;4:285-90.
30. Gomara MJ, Haro I. Synthetic peptides for the immunodiagnosis of human diseases. Curr Med Chem 2007;14: 531-46.
31. Noya, O, Patarroyo ME, Guzman F, Alarcon de Noya B. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci 2003;4:299-308.
32. Horii M, Matsumoto T, Uemura S, Sugawara Y, Takitsume A, Ueda T, et al. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function. J Cardiol 2013; 61:410-6.
33. Mansor R, Mullen W, Albalat A, Zerefos P, Mischak H, Barrett DC, et al. A peptidomic approach to biomarker discovery for bovine mastitis. J Proteomics 2013; 85:89-98.
34. Cho B, Jeon B-Y, Kim J, Noh J, Kim J, Park M, et al. Expression and evaluation of chikungunya virus E1 and E2 envelope proteins for serodiagnosis of chikungunya virus infection. Yonsei Med J 2008;49:828-35.
35. Kumar J, Khan M, Gupta G, Bhoopati M, Lakshmana Rao PV, Parida M. Production, characterization, and application of monoclonal antibodies specific to recombinant (E2) structural protein in antigen-capture ELISA for clinical diagnosis of chikungunya virus. Viral Immunol 2012;25:153-60.
36. Khan M, Dhanwani R, Rao PV, Parida M. Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virusneutralizing antibodies in mice. Virus Res 2012;167:236-46.
37. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, et al. Glycoprotein organization of chikungunya virus particles revealed by x-ray crystallography. Nature 2010;468:709-12.
38. Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, et al. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. JImmunol 2011;186:3258-64.
39. Bréhina A-C, Rubrechtb L, Sancheza ME, Maréchala V, Frenkiela M-P, Lapalud D, et al. Production and characterization of mouse monoclonal antibodies reactive to chikungunya envelope E2 glycoprotein. Virology 2008;371:185-95.
40. Lee CY, Kam YW, Fric J, Malleret B, Koh EG, Prakash C, et al. Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. PLoS Pathog 2011;12:e1002390.
41. Morey SH, Kashyap RS, Purohit HJ, Taori GM, Daginawala HF. An approach towards peptide-based antibody detection for diagnosis of chikungunya infection. Biomarkers 2010;6:546-52.
42. Kam YW, Lum FM, Teo TH, Lee WW, Simarmata D, Harjanto S, et al. Early neutralizing IgG response to chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol Med 2012;4:330-43.
43. Ng LC, Hapuarachchi HC. Tracing the path of chikungunya virusevolution and adaptation. Infect Genet Evol 2010;10:876-85.
44. Khan AH, Morita K, Parquet MM, Hasebe F, Mathenge EG, Igarashi A. Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site. J Gen Virol 2002;83:3075-84.
45. Yergolkar PN, Tandale BV, Arankalle VA, Sathe PS, Sudeep AB, Gandhe SS, et al. Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis 2006;12:1580-3.
46. Conway JF, Watts NR, Belnap DM, Cheng N, Stahl SJ, Wingfield PT, et al. Characterization of a conformational epitope on hepatitis b virus core antigen and quasiequivalent variations in antibody binding, J Virol 2003;77:6466-73.
47. Kowalzik S, Xuan NV, Weissbrich B, Scheiner B, Schied T, Drosten C, et al. Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol 2008;197:381-6.
48. Papadea C, Check IJ. Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic and clinical aspects. Crit Rev Clin Lab Sci 1989;27:27-58.
49. Kam Y-W, Lum F-M, Teo T-H, Lee WW, Simarmata D, Harjanto S, et al. Early neutralizing IgG response to chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol Med 2012;4:330-43.
50. Kam YW, Lee WW, Simarmata D, Harjanto S, Teng TS, Tolou H, et al. Longitudinal analysis of the human antibody response to chikungunya virus infection: implications for serodiagnosis and vaccine development. J Virol 2012;86:13005-15.
51. Ali R, Naqvi RA, Kumar S, Bhat AA, Rao DN. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of yersinia pestis showed enhanced Th1 immune response in murine model. Scand J Immunol 2013;77:361-71.
52. Pomponi D, Bernardi ML, Liso M, Palazzo P, Tuppo L, Rafaiani C, et al. Allergen micro-bead array for IgE detection: a feasibility study using allergenic molecules tested on a flexible multiplex flow cytometric immunoassay. PLoS One 2012;7:e35.